customer.service@microbix.com 
+1-905-361-8910 +1-800-794-6694 (Toll Free)
Record Q2 Sales of $4.9 million, Q2 Net Earnings of $0.7 million MISSISSAUGA, May 12, 2022 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...
Microbix Reports Record Results for Q2 Fiscal 2022
read more
NEWS RELEASES
Microbix Presenting Omicron Test Control Results at CVS
QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, CANADA, April 29, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Presenting at the 2022 Bloom Burton Conference
Healthcare Investor Conference in Toronto on May 2 & 3, 2022 MISSISSAUGA, CANADA, April 28, 2022 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Presenting Respiratory Virus Controls Data at Two Events
QAPs Supporting Tests That Simultaneously Detect Multiple Respiratory Viruses MISSISSAUGA, CANADA, April 19, 2022 – Microbix Biosystems...
Microbix Presenting HPV Product Results at EUROGIN
QAPs Supporting Screening-Tests for High-Risk Human Papilloma Viruses MISSISSAUGA, CANADA, April 8, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Announces Annual and Special Meeting Voting Results
Microbix Announces Annual and Special Meeting Voting Results MISSISSAUGA, CANADA, March 31, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Invests to Further Scale Its Business
Implementing MasterControl® and NetSuite® Solutions to Enable Rapid Growth MISSISSAUGA, CANADA, March 29, 2022 – Microbix Biosystems Inc....
Microbix Announces Issuance of Stock Options
Using Shareholder-Approved Plan to Incentivize and Retain MISSISSAUGA, CANADA, February 24, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Announces Nomination to Board of Directors
For Appointment of Jennifer Stewart, Accomplished Business Leader MISSISSAUGA, CANADA, February 22, 2022 – Microbix Biosystems Inc. (TSX:...
Microbix Presenting at Capital Conference in B.C.
Meetings with Growth-Oriented Investors, February 18-20, 2022 MISSISSAUGA, CANADA, February 17, 2022 - Microbix Biosystems Inc. (TSX: MBX,...
Microbix Advances Commissioning of Sites Two and Three
Expansion of Capacity for Manufacturing of QAPs & DxTM MISSISSAUGA, CANADA, February 15, 2022 – Microbix Biosystems Inc. (TSX: MBX,...
Microbix Reports Record Results for Q1 Fiscal 2022
Record Q1 Sales of $4.9 million, Record Q1 Net Earnings of $0.9 million MISSISSAUGA, February 10, 2022 - Microbix Biosystems Inc. (TSX:...
